Login to Your Account



Contravir's HBV drug unvexed by Viread, key to curative combo plan

By Michael Fitzhugh
Staff Writer

Thursday, October 13, 2016

Contravir Pharmaceuticals Inc. reported that 10 hepatitis B patients treated with CMX157 saw viral load reductions comparable to those achieved with Viread.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription